Results 231 to 240 of about 107,669 (285)

Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines. [PDF]

Nat Commun, 2019
Tovar M, Arregui S, Marinova D, Martín C, Sanz J, Moreno Y.   +5 more
europepmc   +1 more source

DNA vaccine encoding mycobacterial HSP65 protein protects guinea pigs against a virulent strain of Mycobacterium tuberculosis

, 2005
Lúcia de Paula, Camila Matias‐Peres, Daniela Carlos, Carlos A. Sorgi, Célio Lopes Silva, Edson Soares Garcia, Lúcia Helena Faccioli   +6 more
openalex   +1 more source

Systems approach to tuberculosis vaccine development

, 2013
Charles C. Wang, Bingdong Zhu, Xionglin Fan, Brigitte Gicquel, Ying Zhang   +4 more
openalex   +2 more sources

MTB-ImmunogenKG: An LLM-assisted knowledge graph for antigen selection in tuberculosis vaccine research

Jielong Peng, Xinhao Zhuang, Yingying Chen, Haitong Xu, Yunjie Du, Bingdong Zhu, Chen Zhu, Ying Wang, Yunchao Ling, Guoqing Zhang   +9 more
openalex   +1 more source

Correction for Vani et al., Parameters that influence the prediction of epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosis

, 2009

openalex   +1 more source

Tuberculosis vaccines

, 2008
Kim Connelly Smith, Ian M. Orme, Jeffrey R. Starke   +2 more
openaire   +1 more source

EU-U.S. SUMMIT, 8981/00 (Presse 193). 31 May 2000 [PDF]

, 2000

core  

Search for a New TB Vaccine [PDF]

, 2012
Ifakara Health Institute, (IHI)
core  

Bovine Tuberculosis in Cattle and Badgers [PDF]

, 1997
Anderson, R, Clutton-Brock, T, Donnelley, C, Krebs, J, Morrison, Ivan, Young, D   +5 more
core